4Filed Sep 7, 8:00 PM ET

CollPlant (CLGN) Deputy CEO/CFO Eran Receives RSU Award

$CLGN · CollPlant Biotechnologies Ltd

Research Summary

AI-generated summary of this SEC filing

Updated

CollPlant (CLGN) Deputy CEO/CFO Eran Receives RSU Award

What Happened

  • Rotem Eran, CollPlant's Deputy CEO and CFO, was granted 510,372 restricted share units (RSUs) on September 3, 2026. The award was reported at $0.00 per unit (an equity grant, not a cash purchase). The Form 4’s reported total includes the 510,372 newly awarded RSUs plus 3,375 ordinary shares and 2,625 previously-awarded RSUs, for 516,372 securities reported in total.
  • The RSUs are contingent rights to one ordinary share each and were adjusted for a 1-for-10 reverse stock split effective September 4, 2026.

Key Details

  • Transaction date: 2026-09-03; Form 4 filed 2026-09-08 (filing appears timely given the Sept. 7 U.S. holiday/Labor Day).
  • Grant type/code: A (award/grant); price per share reported = $0.00 (award).
  • Shares / RSUs reported after transaction: 516,372 total (3,375 ordinary shares + 512,997 RSUs, where 512,997 = 510,372 newly awarded RSUs + 2,625 previously-awarded RSUs).
  • Vesting: 30% of the new RSUs vest on Sept 3, 2027; the remaining 70% vest in equal installments every three months over the next four years, fully vesting on Sept 3, 2031, subject to continued service (per footnote).
  • Reverse split: A 1-for-10 reverse stock split effective Sept 4, 2026 was applied; reported amounts are post-split.
  • No sale or purchase occurred; this was a compensation award (not a market trade). No tax-withholding or 10b5-1 plan noted in the filing.

Context

  • RSUs are a common form of executive compensation that convert to ordinary shares only after vesting; they do not represent immediate cash proceeds or open-market buying/selling. Because vesting is service-based and stretched over years, this grant primarily reflects compensation structure rather than an immediate market sentiment signal.